Adiponectin mediates an antiproliferative response in human MDA-MB 231 breast cancer cells.
暂无分享,去创建一个
M. Dieudonné | E. Dos Santos | M. Leneveu | Y. Giudicelli | R. Pecquery | V. Sérazin | D. Benaîtreau
[1] G. Steinberg,et al. Adipose tissue as an endocrine organ , 2010, Molecular and Cellular Endocrinology.
[2] H. Nagawa,et al. Adiponectin inhibits the growth and peritoneal metastasis of gastric cancer through its specific membrane receptors AdipoR1 and AdipoR2 , 2007, Cancer science.
[3] Xiaohe Yang,et al. Caspase-3 status is a determinant of the differential responses to genistein between MDA-MB-231 and MCF-7 breast cancer cells. , 2007, Biochimica et biophysica acta.
[4] H. Randeva,et al. The regulation of adiponectin receptors in human prostate cancer cell lines. , 2006, Biochemical and biophysical research communications.
[5] T. Funahashi,et al. Adiponectin downregulates its own production and the expression of its AdipoR2 receptor in transgenic mice. , 2006, Biochemical and biophysical research communications.
[6] M. Dieudonné,et al. Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells. , 2006, Biochemical and biophysical research communications.
[7] S. Sukumar,et al. Molecular links between obesity and breast cancer. , 2006, Endocrine-related cancer.
[8] E. Surmacz,et al. Leptin and cancer , 2006, Journal of cellular physiology.
[9] C. Mantzoros,et al. Adiponectin and cancer: a systematic review , 2006, British Journal of Cancer.
[10] J. Bub,et al. Adiponectin as a growth inhibitor in prostate cancer cells. , 2006, Biochemical and biophysical research communications.
[11] S. B. Pedersen,et al. Adiponectin Receptors in Human Adipose Tissue: Effects of Obesity, Weight Loss, and Fat Depots , 2006, Obesity.
[12] H. Xie,et al. Adiponectin stimulates human osteoblasts proliferation and differentiation via the MAPK signaling pathway. , 2005, Experimental cell research.
[13] J. Bub,et al. Adiponectin activates c-Jun NH2-terminal kinase and inhibits signal transducer and activator of transcription 3. , 2005, Biochemical and biophysical research communications.
[14] F. Casanueva,et al. Expression and regulation of adiponectin and receptor in human and rat placenta. , 2005, The Journal of clinical endocrinology and metabolism.
[15] J. Carroll,et al. Estrogen and insulin/IGF-1 cooperatively stimulate cell cycle progression in MCF-7 breast cancer cells through differential regulation of c-Myc and cyclin D1 , 2005, Molecular and Cellular Endocrinology.
[16] T. Motyl,et al. Kinetics of Smac/DIABLO release from mitochondria during apoptosis of MCF‐7 breast cancer cells , 2004, Cell biology international.
[17] C. Drevon,et al. Adiponectin and its receptors are expressed in bone-forming cells. , 2004, Bone.
[18] Kazunori Shimada,et al. Adiponectin and atherosclerotic disease. , 2004, Clinica chimica acta; international journal of clinical chemistry.
[19] C. Mantzoros,et al. Adiponectin and breast cancer risk. , 2004, The Journal of clinical endocrinology and metabolism.
[20] S. Kihara,et al. Association of serum adiponectin levels with breast cancer risk. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[21] Xin Hu,et al. Leptin--a growth factor in normal and malignant breast cells and for normal mammary gland development. , 2003, Journal of the National Cancer Institute.
[22] Philippe Froguel,et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects , 2003, Nature.
[23] D. Rose,et al. Breast Cancer and Obesity: An Update , 2003, Nutrition and cancer.
[24] M. Dieudonné,et al. Leptin mediates a proliferative response in human MCF7 breast cancer cells. , 2002, Biochemical and biophysical research communications.
[25] M. Dieudonné,et al. Proadipogenic effect of leptin on rat preadipocytes in vitro: activation of MAPK and STAT3 signaling pathways. , 2002, American journal of physiology. Cell physiology.
[26] J. Peyrat,et al. Identification of leptin receptors in human breast cancer: functional activity in the T47-D breast cancer cell line , 2002, Molecular and Cellular Endocrinology.
[27] J. Xu,et al. Different effects of genistein on molecular markers related to apoptosis in two phenotypically dissimilar breast cancer cell lines , 2001, Journal of cellular biochemistry.
[28] T. Funahashi,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 2001 by The Endocrine Society Hypoadiponectinemia in Obesity and Type 2 Diabetes: Close Association with Insulin Resistance , 2022 .
[29] Yiwei Li,et al. Induction of apoptosis in breast cancer cells MDA-MB-231 by genistein , 1999, Oncogene.
[30] T Nakamura,et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. , 1999, Biochemical and biophysical research communications.
[31] R. Sutherland,et al. c-Myc or Cyclin D1 Mimics Estrogen Effects on Cyclin E-Cdk2 Activation and Cell Cycle Reentry , 1998, Molecular and Cellular Biology.
[32] R. D'Agostino,et al. Body fat distribution and breast cancer in the Framingham Study. , 1990, Journal of the National Cancer Institute.
[33] M. M. Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.
[34] C. Mantzoros,et al. Total and high-molecular-weight adiponectin in breast cancer: in vitro and in vivo studies. , 2007, The Journal of clinical endocrinology and metabolism.
[35] G. Chrousos,et al. Antiproliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer. , 2007, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[36] M. Haluzík,et al. Adipocytokines and cancer. , 2006, Physiological research.